Anúncio
Anúncio
INCY
Incyte Genomics Inc
110.61
USDPatrocinado
+3.95
+3.71%
07 de jan., 16:00 UTC -5
Encerrado
Pós-Mercado
111.58
+0.96
+0.87%
Relatórios de Lucros INCY
Rácio de surpresa positiva
INCY separação 20 de 39 últimas estimativas.
51%
Próximo Relatório
Data do Próximo Relatório
09 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.38B
/$1.95
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+0.81%
/-13.33%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+16.83%
/+36.36%
Incyte Genomics Inc earnings per share and revenue
On 28 de out. de 2025, INCY reported earnings of 2.25 USD per share (EPS) for Q3 25, beating the estimate of 1.68 USD, resulting in a 33.74% surprise. Revenue reached 1.37 bilhão, compared to an expected 1.28 bilhão, with a 6.70% difference. The market reacted with a -1.54% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 25 analistas forecast an EPS of 1.95 USD, with revenue projected to reach 1.38 bilhão USD, implying an diminuir of -13.33% EPS, and aumentar of 0.81% in Revenue from the last quarter.
FAQ
What were Incyte Genomics Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Incyte Genomics Inc reported EPS of $2.25, beating estimates by 33.74%, and revenue of $1.37B, 6.7% above expectations.
How did the market react to Incyte Genomics Inc's Q3 2025 earnings?
The stock price moved down -1.54%, changed from $93.08 before the earnings release to $91.65 the day after.
When is Incyte Genomics Inc expected to report next?
The next earning report is scheduled for 09 de fev. de 2026.
What are the forecasts for Incyte Genomics Inc's next earnings report?
Based on 25
analistas, Incyte Genomics Inc is expected to report EPS of $1.95 and revenue of $1.38B for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio